Skip to content

MESO

Mesoblast Ltd.

NASDAQ · Healthcare · Biotechnology · AU

$15.13
+1.75%
Ask drillr

Next report

Analyst consensus

Next report date
Mar 4, 2027
EPS estimate
-$0.15
Revenue estimate
$87.9M

Latest reported

Last report date
Aug 26, 2026
EPS actual
-$0.13
EPS estimate
-$0.11
Revenue actual
$69.0M
Revenue estimate
$67.0M

Track record

Trailing twelve quarters

EPS beats (12Q)
4
EPS misses (12Q)
8
EPS in line (12Q)
0
Avg surprise (4Q)
+21.9%
Revenue beats (12Q)
2
Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Aug 26, 2026-$0.11-$0.13Miss -23.22%$69.0M
Sep 3, 2025-$0.20-$0.21Miss -6.43%$7.0M
Feb 26, 2025-$0.25-$0.02Beat 91.61%$1.6M
Jul 4, 2024-$0.35-$0.26Beat 25.71%
Aug 30, 2023-$0.32-$0.28Beat 12.50%$2.1M
May 25, 2023-$0.36-$0.26Beat 27.78%$1.9M
Feb 27, 2023-$0.30-$0.34Miss -13.33%$2.0M
Nov 22, 2022-$0.20-$0.24Miss -20.00%$1.4M
Aug 30, 2022-$0.10-$0.34Miss -240.00%$2.2M
May 31, 2022-$0.16-$0.32Miss -100.00%$2.0M
Feb 24, 2022-$0.39-$0.40Miss -3.74%$2.4M
Nov 23, 2021-$0.30-$0.34Miss -13.33%$3.6M

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Mar 4, 2027